247 related articles for article (PubMed ID: 25378241)
81. Current methods in quantifying ROS and oxidative damage in Caenorhabditis elegans and other model organism of aging.
Labuschagne CF; Brenkman AB
Ageing Res Rev; 2013 Sep; 12(4):918-30. PubMed ID: 24080227
[TBL] [Abstract][Full Text] [Related]
82. Cardiovascular pharmacology and physiology of the isoprostanes.
Cracowski JL; Durand T
Fundam Clin Pharmacol; 2006 Oct; 20(5):417-27. PubMed ID: 16968413
[TBL] [Abstract][Full Text] [Related]
83. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress.
Morrow JD; Roberts LJ
Methods Enzymol; 1999; 300():3-12. PubMed ID: 9919502
[TBL] [Abstract][Full Text] [Related]
84. Lipid peroxidation, isoprostanes and vascular damage.
Minuz P; Fava C; Lechi A
Pharmacol Rep; 2006; 58 Suppl():57-68. PubMed ID: 17332673
[TBL] [Abstract][Full Text] [Related]
85. The biochemistry of the isoprostane, neuroprostane, and isofuran Pathways of lipid peroxidation.
Roberts LJ; Fessel JP; Davies SS
Brain Pathol; 2005 Apr; 15(2):143-8. PubMed ID: 15912887
[TBL] [Abstract][Full Text] [Related]
86. [LC-MS/MS as a method for the determination of isoprostanes: a brief review].
Król MB; Brzeźnicki S
Med Pr; 2023 May; 74(2):119-125. PubMed ID: 36946654
[TBL] [Abstract][Full Text] [Related]
87. Adrenic acid non-enzymatic peroxidation products in biofluids of moderate preterm infants.
Sánchez-Illana Á; Shah V; Piñeiro-Ramos JD; Di Fiore JM; Quintás G; Raffay TM; MacFarlane PM; Martin RJ; Kuligowski J
Free Radic Biol Med; 2019 Oct; 142():107-112. PubMed ID: 30818053
[TBL] [Abstract][Full Text] [Related]
88. The isoprostanes: unique products of arachidonic acid oxidation-a review.
Fam SS; Morrow JD
Curr Med Chem; 2003 Sep; 10(17):1723-40. PubMed ID: 12871112
[TBL] [Abstract][Full Text] [Related]
89. Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.
Bauer J; Ripperger A; Frantz S; Ergün S; Schwedhelm E; Benndorf RA
Br J Pharmacol; 2014 Jul; 171(13):3115-31. PubMed ID: 24646155
[TBL] [Abstract][Full Text] [Related]
90. Isoprostanes and isofurans as non-traditional risk factors for cardiovascular disease among Canadian Inuit.
Alkazemi D; Egeland GM; Roberts LJ; Kubow S
Free Radic Res; 2012 Oct; 46(10):1258-66. PubMed ID: 22712480
[TBL] [Abstract][Full Text] [Related]
91. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications.
Cracowski JL; Durand T; Bessard G
Trends Pharmacol Sci; 2002 Aug; 23(8):360-6. PubMed ID: 12377577
[TBL] [Abstract][Full Text] [Related]
92. F(2)-isoprostanes as novel biomarkers for type 2 diabetes: a review.
Kaviarasan S; Muniandy S; Qvist R; Ismail IS
J Clin Biochem Nutr; 2009 Jul; 45(1):1-8. PubMed ID: 19590700
[TBL] [Abstract][Full Text] [Related]
93. First Total Syntheses of Novel Non-Enzymatic Polyunsaturated Fatty Acid Metabolites and Their Identification in Edible Oils.
Pavlíčková T; Bultel-Poncé V; Guy A; Rocher A; Reversat G; Vigor C; Durand T; Galano JM; Jahn U; Oger C
Chemistry; 2020 Aug; 26(44):10090-10098. PubMed ID: 32531118
[TBL] [Abstract][Full Text] [Related]
94. Today's oxidative stress markers.
Czerska M; Mikołajewska K; Zieliński M; Gromadzińska J; Wąsowicz W
Med Pr; 2015; 66(3):393-405. PubMed ID: 26325052
[TBL] [Abstract][Full Text] [Related]
95. Lipid peroxidation products as oxidative stress biomarkers.
Niki E
Biofactors; 2008; 34(2):171-80. PubMed ID: 19706982
[TBL] [Abstract][Full Text] [Related]
96. Omega-3 and -6 fatty acids allocate somatic and germline lipids to ensure fitness during nutrient and oxidative stress in Caenorhabditis elegans.
Lynn DA; Dalton HM; Sowa JN; Wang MC; Soukas AA; Curran SP
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15378-83. PubMed ID: 26621724
[TBL] [Abstract][Full Text] [Related]
97. The isoprostanes: unique bioactive products of lipid peroxidation. An overview.
Liu TZ; Stern A; Morrow JD
J Biomed Sci; 1998; 5(6):415-20. PubMed ID: 9845844
[TBL] [Abstract][Full Text] [Related]
98. Are isoprostanes a clinical marker for antioxidant drug investigation?
Souvignet C; Cracowski JL; Stanke-Labesque F; Bessard G
Fundam Clin Pharmacol; 2000; 14(1):1-10. PubMed ID: 10681068
[TBL] [Abstract][Full Text] [Related]
99. [Perhydroxyl Radical (HO2^(•)) as Inducer of the Isoprostane Lipid Peroxidation in Mitochondria].
Panov A
Mol Biol (Mosk); 2018; 52(3):347-359. PubMed ID: 29989570
[TBL] [Abstract][Full Text] [Related]
100. Human biochemistry of the isoprostane pathway.
Milne GL; Yin H; Morrow JD
J Biol Chem; 2008 Jun; 283(23):15533-7. PubMed ID: 18285331
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
